171 related articles for article (PubMed ID: 35183626)
1. Multidrug-resistant enteric bacteria in Nigeria and potential use of bacteriophages as biocontrol.
Oyejobi GK; Sule WF; Akinde SB; Khan FM; Ogolla F
Sci Total Environ; 2022 Jun; 824():153842. PubMed ID: 35183626
[TBL] [Abstract][Full Text] [Related]
2. A Quest to the Therapeutic Arsenal: Novel Strategies to Combat Multidrug- resistant Bacteria.
Ashwath P; Sannejal AD
Curr Gene Ther; 2022; 22(2):79-88. PubMed ID: 33874870
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of multiple drug resistant enteric bacteria: Evidence from a teaching hospital in Southwest Nigeria.
Kayode A; Okunrounmu P; Olagbende A; Adedokun O; Hassan AW; Atilola G
J Infect Public Health; 2020 Apr; 13(4):651-656. PubMed ID: 31522967
[TBL] [Abstract][Full Text] [Related]
4. Molecular Insights into Antimicrobial Resistance Traits of Multidrug Resistant Enteric Pathogens isolated from India.
Kumar P; Bag S; Ghosh TS; Dey P; Dayal M; Saha B; Verma J; Pant A; Saxena S; Desigamani A; Rana P; Kumar D; Sharma NC; Hanpude P; Maiti TK; Mukhopadhyay AK; Bhadra RK; Nair GB; Ramamurthy T; Das B
Sci Rep; 2017 Oct; 7(1):14468. PubMed ID: 29089611
[TBL] [Abstract][Full Text] [Related]
5. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
Viertel TM; Ritter K; Horz HP
J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
[TBL] [Abstract][Full Text] [Related]
6. The disparate effects of bacteriophages on antibiotic-resistant bacteria.
Torres-Barceló C
Emerg Microbes Infect; 2018 Oct; 7(1):168. PubMed ID: 30302018
[TBL] [Abstract][Full Text] [Related]
7. Bacteriophages as an Alternative Method for Control of Zoonotic and Foodborne Pathogens.
Alomari MMM; Dec M; Urban-Chmiel R
Viruses; 2021 Nov; 13(12):. PubMed ID: 34960617
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of enteric bacteria and their antimicrobial susceptibility patterns among food handlers in Gondar town, Northwest Ethiopia.
Getie M; Abebe W; Tessema B
Antimicrob Resist Infect Control; 2019; 8():111. PubMed ID: 31321030
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of lytic bacteriophages for control of multidrug-resistant Salmonella Typhimurium.
Jung LS; Ding T; Ahn J
Ann Clin Microbiol Antimicrob; 2017 Sep; 16(1):66. PubMed ID: 28938899
[TBL] [Abstract][Full Text] [Related]
10. Bacteriophages: the possible solution to treat infections caused by pathogenic bacteria.
El-Shibiny A; El-Sahhar S
Can J Microbiol; 2017 Nov; 63(11):865-879. PubMed ID: 28863269
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of potentially zoonotic and cephalosporin resistant enteric bacteria among shelter dogs in the Central and South-Central Appalachia.
Verma A; Carney K; Taylor M; Amsler K; Morgan J; Gruszynski K; Erol E; Carter C; Locke S; Callipare A; Shah DH
BMC Vet Res; 2021 Sep; 17(1):313. PubMed ID: 34563197
[TBL] [Abstract][Full Text] [Related]
12. Bacteriophages, a New Therapeutic Solution for Inhibiting Multidrug-Resistant Bacteria Causing Wound Infection: Lesson from Animal Models and Clinical Trials.
Taati Moghadam M; Khoshbayan A; Chegini Z; Farahani I; Shariati A
Drug Des Devel Ther; 2020; 14():1867-1883. PubMed ID: 32523333
[TBL] [Abstract][Full Text] [Related]
13. The role of the human gut microbiota in colonization and infection with multidrug-resistant bacteria.
Wuethrich I; W Pelzer B; Khodamoradi Y; Vehreschild MJGT
Gut Microbes; 2021; 13(1):1-13. PubMed ID: 33870869
[TBL] [Abstract][Full Text] [Related]
14. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.
Medina E; Pieper DH
Curr Top Microbiol Immunol; 2016; 398():3-33. PubMed ID: 27406189
[TBL] [Abstract][Full Text] [Related]
15. [Bacteriophages in the battle against multidrug resistant bacteria].
van der Meer JWM; Vandenbroucke-Grauls CMJE
Ned Tijdschr Geneeskd; 2018; 162():D2433. PubMed ID: 29600928
[TBL] [Abstract][Full Text] [Related]
16. [Surveillance of resistance in the intensive care units using a cumulative antibiogram].
Yürüyen C; Daldaban Dinçer Ş; Yanılmaz Ö; Boz ES; Aksaray S
Mikrobiyol Bul; 2018 Oct; 52(4):329-339. PubMed ID: 30522419
[TBL] [Abstract][Full Text] [Related]
17. Reviewing the journey to the clinical application of bacteriophages to treat multi-drug-resistant bacteria.
Mboowa G
BMC Infect Dis; 2023 Oct; 23(1):654. PubMed ID: 37789281
[TBL] [Abstract][Full Text] [Related]
18. A bacteriophage cocktail targeting Escherichia coli reduces E. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota.
Cieplak T; Soffer N; Sulakvelidze A; Nielsen DS
Gut Microbes; 2018; 9(5):391-399. PubMed ID: 29517960
[TBL] [Abstract][Full Text] [Related]
19. Bacteriophages for ESKAPE: role in pathogenicity and measures of control.
Patil A; Banerji R; Kanojiya P; Koratkar S; Saroj S
Expert Rev Anti Infect Ther; 2021 Jul; 19(7):845-865. PubMed ID: 33261536
[TBL] [Abstract][Full Text] [Related]
20. Intestinal Bacteriophage Therapy: Looking for Optimal Efficacy.
Javaudin F; Latour C; Debarbieux L; Lamy-Besnier Q
Clin Microbiol Rev; 2021 Dec; 34(4):e0013621. PubMed ID: 34668734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
